Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.71 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.71 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.51 |
| ▸ | NOD1 | Q9Y239 | 10/20 | 0.43 |
| ▸ | FNTA | P49354 | 2/20 | 0.39 |
| ▸ | FNTB | P49356 | 2/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9421282 | 0.90 | PTGS1 (0.74) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL10797351 | 0.89 | PTGS1 (0.76) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL9817253 | 0.89 | PTGS1 (0.76) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL680902 | 0.89 | PTGS1 (0.76) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL2928607 | 0.88 | PTGS1 (0.68) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL2153081 | 0.86 | PTGS1 (0.76) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL5934999 | 0.86 | PTGS1 (0.76) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL677435 | 0.86 | PTGS1 (0.80) | PTGS1GSTK1GLO1NOD1FNTA | |
| SCHEMBL13160954 | 0.86 | PTGS1 (0.80) | PTGS1GSTK1GLO1NOD1FNTA | |
| Glutathione Ethyl Ester SCHEMBL7530345 | 0.86 | PTGS1 (0.71) | PTGS1GSTK1GLO1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119350436-A | Method for synthesizing acetyl glutathione by biological enzyme method | 上海克琴科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| US-11547757-B2 | Elimination of exotic pathogens | Healing Oil Extracts, LLC. (US) | 2023-01-10 | — | — | US | claimed |
| WO-2021220124-A1 | A PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT USING L-CARNOSINE AND GLUTATHIONE, ITS PRECURSORS OR DERIVATIVES THEREOF | SINGH SHYAM SUNDER (IN) | 2021-11-04 | — | — | WO | claimed |
| US-20110160305-A1 | Oral Delivery of Therapeutic Doses of Glutathione | AGB INNOVATIONS, LLC | 2011-06-30 | — | — | US | claimed |
| EP-1888765-A4 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF VENOUS THROMBOEMBOLIC DISEASE | BIOSITE INC (US) | 2008-11-05 | — | — | EP | claimed |
| EP-1888765-A2 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF VENOUS THROMBOEMBOLIC DISEASE | Biosite Incorporated (US) | 2008-02-20 | — | — | EP | claimed |
| WO-2006135781-A2 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF VENOUS THROMBOEMBOLIC DISEASE | BIOSITE, INC. (US) | 2006-12-21 | — | — | WO | claimed |
| EP-0948258-A4 | BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS | YISSUM RES DEV CO (IL) | 2004-12-01 | — | — | EP | claimed |
| EP-0948258-A1 | BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1999-10-13 | — | — | EP | claimed |
| WO-1998029375-A1 | BRAIN TARGETED LOW MOLECULAR WEIGHT HYDROPHOBIC ANTIOXIDANT COMPOUNDS | YISSUM RESEARCH AND DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1998-07-09 | — | — | WO | claimed |
| WO-2025233092-A1 | COMPOSITION FOR MAINTAINING AND/OR IMPROVING EYE HEALTH OR VISUAL FUNCTION | Société des Produits Nestlé S.A. (CH) | 2025-11-13 | — | — | WO | disclosed |
| EP-4618963-A1 | COMBINATION FOR USE IN BRAIN HEALTH AND INCREASING MENTAL PERFORMANCE | Société des Produits Nestlé S.A. (CH) | 2025-09-24 | — | — | EP | disclosed |
| CN-119350436-A | Method for synthesizing acetyl glutathione by biological enzyme method | 上海克琴科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350436-A | Method for synthesizing acetyl glutathione by biological enzyme method | 上海克琴科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-119350436-A | Method for synthesizing acetyl glutathione by biological enzyme method | 上海克琴科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-100355452-C | Carbonyl stress-ameliorating agents | KUROKAWA KIYOSHI (JP) | 2007-12-19 | — | — | CN | disclosed |
| EP-1539023-A2 | TREATMENT OF MULTIPLE SCLEROSIS WITH BRAIN TARGETED ANTI OXIDANT COMPOUNDS | Yissum Research Development Company, of The Hebrew University of Jerusalem (IL) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004012652-A9 | TREATMENT OF MULTIPLE SCLEROSIS WITH BRAIN TARGETED ANTI OXIDANT COMPOUNDS | YISSUM RES DEV CO (IL) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004012652-A2 | TREATMENT OF MULTIPLE SCLEROSIS WITH BRAIN TARGETED ANTI OXIDANT COMPOUNDS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-02-12 | — | — | WO | disclosed |
| CN-1433320-A | Carbonyl stress-ameliorating agents | KUROKAWA KIYOSHI (JP) | 2003-07-30 | — | — | CN | disclosed |